SCHEMBL5046534

SCHEMBL5046534

CN(C)C(=O)c1ccc(C#C[Si](C)(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ACACB O00763 1/20 0.47
EGLN1 Q9GZT9 1/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.41
HDAC4 P56524 1/20 0.40
MTOR P42345 3/20 0.40
PIK3CA P42336 2/20 0.40
MAOB P27338 1/20 0.39
AOC3 Q16853 1/20 0.39
MMP13 P45452 1/20 0.39
KDM4E B2RXH2 2/20 0.37
CYP3A4 P08684 2/20 0.37
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
CYP2D6 P10635 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8049735 0.81 ALDH1A1 (0.43) ALDH1A1HPGDSMN1; SMN2KDM4EMEN1
SCHEMBL9636621 0.79 HPGD (0.47) ALDH1A1HPGDSMN1; SMN2ACACBKDM4E
SCHEMBL6036758 0.79 RARB (0.55) ALDH1A1HPGDSMN1; SMN2ACACBCYP3A4
SCHEMBL13891405 0.79 ALDH1A1 (0.52) ALDH1A1HPGDSMN1; SMN2ACACBEGLN1
SCHEMBL25093690 0.78 NOS1 (0.44) ALDH1A1SMN1; SMN2CYP3A4KMT2ATDP1
SCHEMBL28655847 0.77 MMP2 (0.34) ALDH1A1HPGDKDM4ECYP3A4MEN1
SCHEMBL22259668 0.76 PTGDR2 (0.58) ALDH1A1HPGDSMN1; SMN2ACACBEGLN1
SCHEMBL22259645 0.76 APP (0.55) ALDH1A1HPGDSMN1; SMN2ACACBEGLN1
SCHEMBL22259646 0.76 NSD2 (0.51) ALDH1A1HPGDSMN1; SMN2ACACBEGLN1
SCHEMBL1004649 0.76 ALDH1A1 (0.73) ALDH1A1HPGDSMN1; SMN2HDAC4MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7459480-B2 Benzodioxepine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-12-02 US disclosed
EP-1682528-B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-09-12 EP disclosed
EP-1682528-A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-07-26 EP disclosed
US-20050113374-A1 Benzodioxepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-05-26 US disclosed
WO-2005044814-A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113374-A1 Benzodioxepine derivatives BBOX1, ACOX1, ACOX3 ALDH1A1 361/4885HPGD 260/4885SMN1; SMN2 3955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.